Cargando…

Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner

Detalles Bibliográficos
Autores principales:	Gautam, Archana, Patil, Ajit, Bhattacharya, Jayanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344779/ http://dx.doi.org/10.1186/1471-2334-12-S1-P49

Ejemplares similares

Evidence that Vpu Modulates HIV-1 Gag-Envelope Interaction towards Envelope Incorporation and Infectivity in a Cell Type Dependent Manner
por: Gautam, Archana, et al.
Publicado: (2013)

Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4(+ )T cells
por: Patil, Ajit, et al.
Publicado: (2010)

Mechanistic study of BST-2 down-modulation by HIV-1 Vpu
por: Zhang, Jianyong, et al.
Publicado: (2009)

Post-transcriptional control of HIV-1 Gag expression
por: Phalora, Prabhjeet, et al.
Publicado: (2013)

Effects of mutations on the subcellular distribution and localization of the HIV-1 VPU
por: Goins-Mills, Ricarda, et al.
Publicado: (2006)

Early presentation of HIV-1 KF11Gag and KK10Gag protective epitopes facilitate rapid CD8+ T cell activation and killing of virus infected cells
por: Kløverpris, HN, et al.
Publicado: (2012)

Characterisation of a spumavirus Gag protein
por: Goldstone, David C, et al.
Publicado: (2013)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
por: Rolland, MM, et al.
Publicado: (2009)

Dissecting the contribution of Gag domain in resistance development in HIV-1 patients failing ARV therapy
por: Carli, Ilaria, et al.
Publicado: (2013)

Mapping antigenic variation in HIV-1 envelope
por: Frost, Simon
Publicado: (2013)

Dynamics and frequency of Gag transmitted polymorphisms in Zambia
por: Schaefer, M, et al.
Publicado: (2012)

Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors
por: Christodoulopoulos, Ilias, et al.
Publicado: (2010)

P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection
por: Novitsky, V, et al.
Publicado: (2009)

Mass spectrometry analysis of HIV-1 envelop proteins
por: Galkin, A, et al.
Publicado: (2009)

Characterization and quantitation of fluorescent Gag virus-like particles
por: Gutiérrez-Granados, Sonia, et al.
Publicado: (2013)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu
por: Townsend, Julia A., et al.
Publicado: (2023)

Vpu Downmodulates Two Distinct Targets, Tetherin and Gibbon Ape Leukemia Virus Envelope, through Shared Features in the Vpu Cytoplasmic Tail
por: Lucas, Tiffany M., et al.
Publicado: (2012)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present)
por: Cotton, L, et al.
Publicado: (2012)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Placement of p6pol between tandem repeat HIV-1 protease domains reduces Gag cleavage efficiency
por: Chou, Tin-An, et al.
Publicado: (2013)

Lymphoproliferative responses to HIV-1 Gag p24 antigen and mitogens in HIV-1 subtype CRF01_AE infected Thai patients and HIV-1 seronegative donors
por: Chuenchitra, Thippawan, et al.
Publicado: (2006)

Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 gag
por: Qiu, Jian-Tai, et al.
Publicado: (2006)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains
por: Chetty, S, et al.
Publicado: (2012)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

P17-24. Interfering overlapping epitopes contribute to the subdominance of an HLA-A2-restricted HIV Gag-specific epitope
por: Kan-Mitchell, J, et al.
Publicado: (2009)

Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation
por: Pezeshkian, Nairi, et al.
Publicado: (2019)

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy
por: Culina, S, et al.
Publicado: (2009)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function
por: Kluge, Silvia F, et al.
Publicado: (2013)

Functional analyses of glycosylated gag molecules derived from different gammaretroviruses
por: Cuccurullo, Emilia Cristiana, et al.
Publicado: (2013)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

Modulation of HIV-1-host interaction: role of the Vpu accessory protein
por: Dubé, Mathieu, et al.
Publicado: (2010)

Induction of HIV-specific T-cell responses by gag
por: Van Gulck, Ellen, et al.
Publicado: (2006)

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates
por: Flamar, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jji5v9kjf1sc4rcvhje4nh78mj